BioAdaptives, Inc. (OTC: BDPT) announced that MyndRenew(TM), the nighttime component of its MyndSystem(TM) cognitive health platform, has received TruShield Certified status, confirming compliance with anti-doping standards established by the World Anti-Doping Agency (WADA) and the UFC. Combined with the previously certified MyndMed(TM) daytime formula, the company said MyndSystem(TM) is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes.
The certification strengthens the company's position in the sports nutrition market by supporting potential adoption among professional athletes while also targeting executives and active seniors. BioAdaptives said the milestone could enhance commercialization opportunities, strategic partnerships and broader market adoption as it expands the MyndSystem(TM) platform. Read the full press release here.
The announcement is significant because it addresses a critical concern for athletes: the need for safe, performance-enhancing supplements that do not violate anti-doping rules. By earning TruShield certification, MyndRenew(TM) and the entire MyndSystem(TM) platform gain credibility and trust among professional sports organizations and athletes. This could open doors to partnerships with sports teams, leagues, and individual athletes seeking legal cognitive support.
Beyond athletics, the certification also appeals to a broader demographic, including executives and active seniors who prioritize cognitive health and safety. The WADA compliance assures these consumers that the products meet rigorous standards, potentially increasing market demand. BioAdaptives aims to leverage this certification to expand its presence in the sports nutrition and wellness markets.
BioAdaptives, Inc. develops and markets science-based health and wellness products for humans and animals. Its formulations are grounded in published research on nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function. For more information, visit the company's website at www.bioadaptives.com.
